Patents by Inventor Mariah R. Baughn

Mariah R. Baughn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020146770
    Abstract: The invention provides seven human Ras proteins (RASP) and polynucleotides which identify and encode RASP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of RASP.
    Type: Application
    Filed: January 15, 2002
    Publication date: October 10, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Y. Tom Tang, Preeti Lal, Karl J. Guegler, Neil C. Corley, Chandra Patterson, Sajeev Batra, Mariah R. Baughn
  • Publication number: 20020137038
    Abstract: The invention provides cDNAs which encode mammalian intestinal proteins. It also provides for the use of the cDNAs, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of colon disorders, particularly colon cancer, Crohn's disease, and ulcerative colitis. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.
    Type: Application
    Filed: December 4, 2000
    Publication date: September 26, 2002
    Inventors: Amy W. Lasek, Randi E. Krasnow, Mariah R. Baughn
  • Publication number: 20020137166
    Abstract: The invention provides cDNAs which encode ASIP-related proteins. It also provides for the use of the cDNAs, fragments, complements, and variants thereof and of the encoded proteins, portions thereof and antibodies thereto for diagnosis and treatment of cancer, particularly bladder transitional cell carcinoma. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.
    Type: Application
    Filed: January 9, 2001
    Publication date: September 26, 2002
    Inventors: Roopa Reddy, Y. Tom Tang, Mariah R. Baughn, Randi E. Krasnow
  • Patent number: 6448041
    Abstract: The invention provides a cDNA which encodes a colon cancer marker. It also provides for the use of the cDNA, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of colon disorders, particularly colon cancer and polyps. The invention additionally provides expression vectors and host cells for the production of the protein and a transgenic model system.
    Type: Grant
    Filed: December 18, 2000
    Date of Patent: September 10, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Amy K. Wolven, Randi E. Krasnow, Bridget A. Warren, Mariah R. Baughn
  • Publication number: 20020110858
    Abstract: The invention provides human lymphocytic membrane proteins (LMPRO) and polynucleotides which identify and encode LMPRO. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of LMPRO.
    Type: Application
    Filed: August 13, 2001
    Publication date: August 15, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Y. Tom Tang, Henry Yue, Mariah R. Baughn
  • Publication number: 20020107180
    Abstract: The invention provides human cell surface glycoproteins (CSGP) and polynucleotides which identify and encode CSGP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of CSGP.
    Type: Application
    Filed: November 30, 2001
    Publication date: August 8, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Henry Yue, Neil C. Corley, Karl J. Guegler, Gina A. Gorgone, Mariah R. Baughn
  • Publication number: 20020106664
    Abstract: The invention provides a cDNA which encodes tapasin-like protein. It also provides for the use of the cDNA, protein, and antibody in the diagnosis, prognosis, treatment and evaluation of therapies for cancer. The invention further provides vectors and host cells for the production of the protein and transgenic model systems.
    Type: Application
    Filed: August 20, 2001
    Publication date: August 8, 2002
    Inventors: Preeti G. Lal, Matthew R. Kaser, Mariah R. Baughn
  • Publication number: 20020106655
    Abstract: The invention provides human GPCR proteins and their encoding cDNAs. It also provides for the use of the cDNAs, proteins, and antibodies in the diagnosis, prognosis, treatment and evaluation of therapies for neoplastic disorders and immune response. The invention further provides vectors and host cells for the production of the protein and transgenic model systems.
    Type: Application
    Filed: June 28, 2001
    Publication date: August 8, 2002
    Inventors: Olga Bandman, Preeti G. Lal, Y. Tom Tang, Mariah R. Baughn
  • Publication number: 20020102654
    Abstract: The invention provides human thioredoxin proteins (TRXP) and polynucleotides which identify and encode TRXP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of TRXP.
    Type: Application
    Filed: September 17, 2001
    Publication date: August 1, 2002
    Applicant: Incyte Pharmaceuticals, Inc
    Inventors: Y. Tom Tang, Neil C. Corley, Karl J. Guegler, Chandra Patterson, Mariah R. Baughn
  • Publication number: 20020102649
    Abstract: The invention provides a human transport protein homologs (HTPH) and polynucleotides which identify and encode HTPH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of HTPH.
    Type: Application
    Filed: September 12, 2001
    Publication date: August 1, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Henry Yue, Roopa M. Reddy, Gina A. Gorgone, Neil C. Corley, Yalda Azimzai, Chandra Patterson, Mariah R. Baughn
  • Publication number: 20020103339
    Abstract: The invention provides human ISRE-binding protein (HIBP) and polynucleotides which identify and encode HIBP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of HIBP.
    Type: Application
    Filed: September 5, 2001
    Publication date: August 1, 2002
    Applicant: Incyte pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Preeti Lal, Neil C. Corley, Karl J. Guegler, Chandra Patterson, Mariah R. Baughn, Susan K. Sather, Purvi Shah
  • Publication number: 20020102615
    Abstract: The invention provides a mammalian nucleic acid sequence and fragments thereof. It also provides for the use of these nucleic acid sequences in a model system for the characterization, diagnosis, evaluation, treatment, or prevention of conditions, diseases and disorders associated with expression of the mammalian nucleic acid sequence. The invention additionally provides expression vectors and host cells for the production of the protein encoded by the mammalian nucleic acid sequence.
    Type: Application
    Filed: April 17, 2001
    Publication date: August 1, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Matthew R. Kaser, Mariah R. Baughn
  • Publication number: 20020091244
    Abstract: The invention provides a human signal peptide-containing proteins, the polynucleotides which encode them and methods for their use. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists.
    Type: Application
    Filed: March 5, 2001
    Publication date: July 11, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Preeti Lal, Jennifer L. Hillman, Neil C. Corley, Karl J. Guegler, Mariah R. Baughn, Susan K. Sather, Purvi Shah
  • Publication number: 20020081691
    Abstract: The invention provides a human delta 1-pyrroline-5-carboxylate reductase homolog (P5CRH) and polynucleotides which identify and encode P5CRH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of P5CRH.
    Type: Application
    Filed: July 24, 2001
    Publication date: June 27, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Jennifer L. Hillman, Neil C. Corley, Mariah R. Baughn
  • Publication number: 20020076762
    Abstract: The invention provides full-length expressed genetic markers (FLEXGEM) and polynucleotides which identify and encode FLEXGEM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of FLEXGEM.
    Type: Application
    Filed: August 24, 2001
    Publication date: June 20, 2002
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Henry Yue, Y. Tom Tang, Preeti Lal, Roopa Reddy, Mariah R. Baughn, Junming Yang, Yalda Azimzai
  • Publication number: 20020061301
    Abstract: The invention provides human carbohydrate metabolism enzymes (CARM) and polynucleotides which identify and encode CARM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of CARM.
    Type: Application
    Filed: May 15, 1998
    Publication date: May 23, 2002
    Inventors: OLGA BANDMAN, JENNIFER L. HILLMAN, PREETI LAL, KARL J. GUEGLER, GINA GORGONE, NEIL C. CORLEY, CHANDRA PATTERSON, MARIAH R. BAUGHN
  • Patent number: 6391580
    Abstract: The invention provides seven human Ras proteins (RASP) and polynucleotides which identify and encode RASP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of RASP.
    Type: Grant
    Filed: May 8, 1998
    Date of Patent: May 21, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Jennifer L. Hillman, Y. Tom Tang, Preeti Lal, Karl J. Guegler, Neil C. Corley, Chandra Patterson, Sajeev Batra, Mariah R. Baughn
  • Patent number: 6372431
    Abstract: The present invention relates to mammalian nucleic acid and protein molecules comprising a plurality of nucleic acid and protein molecules. The mammalian nucleic acid molecules can be used as hybridizable array elements in a microarray in diagnostic and therapeutic applications including detecting metabolic and toxicological responses, and in monitoring drug mechanism of action. The protein molecules can be used in a pharmaceutical composition. The present invention also relates to methods for screening compounds and therapeutics for metabolic responses indicative of a toxic compound or molecule.
    Type: Grant
    Filed: November 19, 1999
    Date of Patent: April 16, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Mary Jane Cunningham, Gary B. Zweiger, Matthew R. Kaser, Scott R. Panzer, Jeffrey J. Seilhamer, Henry Yue, Mariah R. Baughn, Yalda Azimzai, Preeti Lal
  • Patent number: 6358923
    Abstract: The invention provides human cell surface glycoproteins (CSGP) and polynucleotides which identify and encode CSGP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of CSGP.
    Type: Grant
    Filed: December 22, 1999
    Date of Patent: March 19, 2002
    Assignee: Incyte Genomics, Inc.
    Inventors: Henry Yue, Neil C. Corley, Karl J. Guegler, Gina A. Gorgone, Mariah R. Baughn
  • Patent number: 6322977
    Abstract: The invention provides a mammalian nucleic acid sequence and fragments thereof. It also provides for the use of the nucleic acid sequence for the characterization, diagnosis, evaluation, treatment, or prevention of conditions, diseases and disorders associated with gene expression and for the production of a model system. The invention additionally provides expression vectors and host cells for the production of the protein encoded by the mammalian nucleic acid sequence.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: November 27, 2001
    Assignee: Incyte Genomics, Inc.
    Inventors: Preeti Lal, Matthew R. Kaser, Mariah R. Baughn